COVID-19 has amplified patient expectations about the quality and safety of care, particularly for the growing number of patients with autoimmune diseases. New provider alternatives for ongoing infusion and injection therapy are reshaping how and where specialized care is delivered.

There’s so many traditions to look forward to when the Thanksgiving holiday rolls around – from the Macy’s Thanksgiving Day Parade to the traditional dinner feast to endless hours of football. However, if you’re one of the many people living with IBD, traditional Thanksgiving foods might be the tradition you look forward to the least.

With the growing cost of care – especially for specialty pharmaceuticals like biologics – combined with new health plans designed to shift more of the financial responsibility to patients, every penny counts. Worrying about covering healthcare costs shouldn’t be at the forefront of anyone’s thoughts. Fortunately, there are a number of non-profit organizations and drug manufacturers that provide patient assistance programs (PAPs) to help shoulder some – and sometimes even all – of the financial burden.